Wick Capital Partners LLC Invests $6.12 Million in Marsh & McLennan Companies, Inc. $MRSH

Wick Capital Partners LLC purchased a new stake in Marsh & McLennan Companies, Inc. (NYSE:MRSH) in the 4th quarter, HoldingsChannel.com reports. The fund purchased 33,009 shares of the financial services provider’s stock, valued at approximately $6,124,000. Marsh & McLennan Companies accounts for about 0.4% of Wick Capital Partners LLC’s investment portfolio, making the stock its 27th largest position.

Several other hedge funds and other institutional investors also recently bought and sold shares of MRSH. Numerai GP LLC lifted its position in Marsh & McLennan Companies by 966.2% during the 3rd quarter. Numerai GP LLC now owns 37,220 shares of the financial services provider’s stock worth $7,501,000 after acquiring an additional 33,729 shares in the last quarter. Swiss Life Asset Management Ltd raised its stake in shares of Marsh & McLennan Companies by 9.5% during the fourth quarter. Swiss Life Asset Management Ltd now owns 134,542 shares of the financial services provider’s stock valued at $24,960,000 after purchasing an additional 11,648 shares during the period. Barclays PLC lifted its position in shares of Marsh & McLennan Companies by 41.7% during the third quarter. Barclays PLC now owns 2,202,372 shares of the financial services provider’s stock worth $443,844,000 after purchasing an additional 647,987 shares in the last quarter. Sarasin & Partners LLP boosted its stake in shares of Marsh & McLennan Companies by 0.9% in the fourth quarter. Sarasin & Partners LLP now owns 934,732 shares of the financial services provider’s stock valued at $173,411,000 after purchasing an additional 8,283 shares during the period. Finally, Brown Brothers Harriman & Co. grew its holdings in Marsh & McLennan Companies by 26.4% during the 3rd quarter. Brown Brothers Harriman & Co. now owns 136,179 shares of the financial services provider’s stock valued at $27,444,000 after purchasing an additional 28,419 shares in the last quarter. 87.99% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the stock. UBS Group decreased their price objective on shares of Marsh & McLennan Companies from $230.00 to $203.00 and set a “buy” rating for the company in a research report on Tuesday, June 9th. Piper Sandler cut their price target on Marsh & McLennan Companies from $190.00 to $182.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 26th. Barclays lowered their price objective on Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating for the company in a research note on Wednesday, April 8th. Weiss Ratings downgraded Marsh & McLennan Companies from a “hold (c)” rating to a “hold (c-)” rating in a report on Monday, May 11th. Finally, Wells Fargo & Company reduced their target price on Marsh & McLennan Companies from $203.00 to $178.00 and set an “equal weight” rating for the company in a research note on Thursday, April 9th. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, ten have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $200.19.

Insider Activity at Marsh & McLennan Companies

In other news, CEO John Q. Doyle sold 16,656 shares of the business’s stock in a transaction that occurred on Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total value of $2,693,441.76. Following the completion of the sale, the chief executive officer directly owned 116,811 shares in the company, valued at approximately $18,889,506.81. The trade was a 12.48% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.38% of the company’s stock.

Marsh & McLennan Companies Stock Performance

Shares of Marsh & McLennan Companies stock opened at $161.96 on Friday. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 1.28. Marsh & McLennan Companies, Inc. has a 1 year low of $156.60 and a 1 year high of $220.32. The stock has a market capitalization of $78.24 billion, a PE ratio of 20.25, a P/E/G ratio of 2.39 and a beta of 0.62.

Marsh & McLennan Companies (NYSE:MRSH) last posted its quarterly earnings results on Thursday, April 16th. The financial services provider reported $3.29 EPS for the quarter, topping analysts’ consensus estimates of $3.21 by $0.08. The business had revenue of $7.30 billion during the quarter. Marsh & McLennan Companies had a return on equity of 31.87% and a net margin of 14.26%.The company’s revenue for the quarter was up 7.6% compared to the same quarter last year. As a group, equities research analysts expect that Marsh & McLennan Companies, Inc. will post 10.38 earnings per share for the current year.

Marsh & McLennan Companies Profile

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.